{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T02:48:04Z","timestamp":1790822884421,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Public Health"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.jiph.2024.102612","type":"journal-article","created":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T00:56:56Z","timestamp":1733187416000},"page":"102612","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Epidemiological characteristics of invasive Aspergillus isolates: Morphology, drug susceptibility, and mutations in azole drug targets"],"prefix":"10.1016","volume":"18","author":[{"given":"Wei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghua","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinsheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jiph.2024.102612_bib1","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.idc.2021.03.008","article-title":"Aspergillosis: epidemiology, diagnosis, and treatment","volume":"35","author":"Cadena","year":"2021","journal-title":"Infect Dis Clin North Am"},{"issue":"1","key":"10.1016\/j.jiph.2024.102612_bib2","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s12866-024-03267-8","article-title":"Hospital distribution, seasonality, time trends and antifungal susceptibility profiles of all Aspergillus species isolated from clinical samples from 2015 to 2022 in a tertiary care hospital","volume":"24","author":"Franconi","year":"2024","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.jiph.2024.102612_bib3","article-title":"The epidemiology of fungal infections in transplant patients","author":"Mahmoud","year":"2024","journal-title":"Biomed J"},{"issue":"5","key":"10.1016\/j.jiph.2024.102612_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2024.106147","article-title":"Utility of an in-house real-time PCR in whole blood samples as a minimally invasive method for early and accurate diagnosis of invasive mould infections","volume":"88","author":"Pandey","year":"2024","journal-title":"J Infect"},{"key":"10.1016\/j.jiph.2024.102612_bib5","doi-asserted-by":"crossref","DOI":"10.1093\/mmy\/myae028","article-title":"Prospective and systematic screening for invasive Aspergillosis in the ICU during the COVID-19 pandemic, a proof of principle for future pandemics","author":"van Grootveld","year":"2024","journal-title":"Med Mycol"},{"issue":"2","key":"10.1016\/j.jiph.2024.102612_bib6","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s11046-024-00836-3","article-title":"Pathogenic Aspergillus strains identification and antifungal susceptibility analysis of 452 cases with otomycosis in Jingzhou, China","volume":"189","author":"Peng","year":"2024","journal-title":"Mycopathologia"},{"key":"10.1016\/j.jiph.2024.102612_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2024.171189","article-title":"Exposure to resistant fungi across working environments and time","volume":"923","author":"Kofoed","year":"2024","journal-title":"Sci Total Environ"},{"issue":"6","key":"10.1016\/j.jiph.2024.102612_bib8","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the european organization for research and treatment of cancer and the mycoses study group education and research consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.jiph.2024.102612_bib9","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1093\/cid\/ciaa1751","article-title":"EORTC\/MSGERC definitions of invasive fungal diseases: summary of activities of the intensive care unit working group","volume":"72","author":"Bassetti","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiph.2024.102612_bib10","unstructured":"CLSI. Epidemiological CutoffValues for Antifungal Susceptibility Testing. CLSI supplement M59. 2018;2nd ed."},{"issue":"1","key":"10.1016\/j.jiph.2024.102612_bib11","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/s12890-020-01259-8","article-title":"The global impact of Aspergillus infection on COPD","volume":"20","author":"Hammond","year":"2020","journal-title":"BMC Pulm Med"},{"issue":"3","key":"10.1016\/j.jiph.2024.102612_bib12","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3314\/mmj.19.004","article-title":"Resistance in the environmental pathogenic fungus Aspergillus fumigatus","volume":"60","author":"Toyotome","year":"2019","journal-title":"Med Mycol J"},{"key":"10.1016\/j.jiph.2024.102612_bib13","article-title":"Clinical and immunological characteristics of Aspergillus fumigatus-sensitized asthma and allergic bronchopulmonary aspergillosis","volume":"13","author":"Chen","year":"2022","journal-title":"Front Immunol"},{"issue":"12","key":"10.1016\/j.jiph.2024.102612_bib14","article-title":"Triazole phenotypes and genotypic characterization of clinical Aspergillus fumigatus isolates in China","volume":"6","author":"Deng","year":"2017","journal-title":"Emerg Microbes Infect"},{"issue":"4","key":"10.1016\/j.jiph.2024.102612_bib15","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s11046-022-00647-4","article-title":"Epidemiology of onychomycosis in Chinese mainland: a 30-year retrospective study","volume":"187","author":"Song","year":"2022","journal-title":"Mycopathologia"},{"issue":"2","key":"10.1016\/j.jiph.2024.102612_bib16","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jmii.2021.03.011","article-title":"Species identification and antifungal susceptibility testing of Aspergillus strains isolated from patients with otomycosis in northern China","volume":"55","author":"Jing","year":"2022","journal-title":"J Microbiol Immunol Infect"},{"issue":"6","key":"10.1016\/j.jiph.2024.102612_bib17","doi-asserted-by":"crossref","first-page":"631","DOI":"10.3109\/13693786.2011.639036","article-title":"A case of bronchial aspergillosis caused by Aspergillus udagawae and its mycological features","volume":"50","author":"Gyotoku","year":"2012","journal-title":"Med Mycol"},{"issue":"1","key":"10.1016\/j.jiph.2024.102612_bib18","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1292\/jvms.12-0119","article-title":"Two cases of feline orbital aspergillosis due to Aspergillus udagawae and A. viridinutans","volume":"75","author":"Kano","year":"2013","journal-title":"J Vet Med Sci"},{"issue":"1","key":"10.1016\/j.jiph.2024.102612_bib19","first-page":"51","article-title":"Disseminated aspergillosis due to Aspergillus udagawae during immunosuppressive treatment for myelodysplastic syndrome]","volume":"62","author":"Kuzume","year":"2021","journal-title":"Rinsho Ketsueki"},{"issue":"11","key":"10.1016\/j.jiph.2024.102612_bib20","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofz449","article-title":"Back pain in a 23-year-old male with X-linked chronic granulomatous disease","volume":"6","author":"Sabo","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jiph.2024.102612_bib21","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.carpath.2017.02.002","article-title":"Fatal fungal endocarditis by Aspergillus udagawae: an emerging cause of invasive aspergillosis","volume":"28","author":"Seki","year":"2017","journal-title":"Cardiovasc Pathol"},{"issue":"12","key":"10.1016\/j.jiph.2024.102612_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e33000","article-title":"A case of Aspergillus quadrilineatus pulmonary infection in China","volume":"10","author":"Zhang","year":"2024","journal-title":"Heliyon"},{"issue":"1","key":"10.1016\/j.jiph.2024.102612_bib23","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.cmi.2018.01.002","article-title":"Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline","volume":"24","author":"Ullmann","year":"2018","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"10.1016\/j.jiph.2024.102612_bib24","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/1348-0421.12957","article-title":"Azole-resistant Aspergillus fumigatus as an emerging worldwide pathogen","volume":"66","author":"Rivelli Zea","year":"2022","journal-title":"Microbiol Immunol"},{"issue":"5","key":"10.1016\/j.jiph.2024.102612_bib25","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.medmal.2019.07.014","article-title":"Azole-resistant Aspergillus fumigatus: a global phenomenon originating in the environment?","volume":"50","author":"Jeanvoine","year":"2020","journal-title":"Med Mal Infect"},{"issue":"7","key":"10.1016\/j.jiph.2024.102612_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009711","article-title":"Azole-resistant Aspergillus fumigatus in the environment: identifying key reservoirs and hotspots of antifungal resistance","volume":"17","author":"Burks","year":"2021","journal-title":"PLoS Pathog"},{"issue":"1","key":"10.1016\/j.jiph.2024.102612_bib27","doi-asserted-by":"crossref","first-page":"9409","DOI":"10.1038\/s41467-024-53790-5","article-title":"CYP5122A1 encodes an essential sterol C4-methyl oxidase in Leishmania donovani and determines the antileishmanial activity of antifungal azoles","volume":"15","author":"Jin","year":"2024","journal-title":"Nat Commun"},{"issue":"11","key":"10.1016\/j.jiph.2024.102612_bib28","doi-asserted-by":"crossref","DOI":"10.1093\/g3journal\/jkac249","article-title":"Analysis of Cyp51 protein sequences shows 4 major Cyp51 gene family groups across fungi","volume":"12","author":"Celia-Sanchez","year":"2022","journal-title":"G3 (Bethesda)"},{"issue":"2","key":"10.1016\/j.jiph.2024.102612_bib29","doi-asserted-by":"crossref","DOI":"10.1128\/jcm.01141-23","article-title":"Trends in the activity of mold-active azole agents against Aspergillus fumigatus clinical isolates with and without cyp51 alterations from Europe and North America (2017-2021)","volume":"62","author":"Pfaller","year":"2024","journal-title":"J Clin Microbiol"},{"issue":"11","key":"10.1016\/j.jiph.2024.102612_bib30","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1038\/s41564-024-01819-2","article-title":"Most azole resistance mutations in the Candida albicans drug target confer cross-resistance without intrinsic fitness cost","volume":"9","author":"B\u00e9dard","year":"2024","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.jiph.2024.102612_bib31","doi-asserted-by":"crossref","DOI":"10.1094\/PDIS-09-24-1962-RE","article-title":"Propiconazole resistance phenotypes in Geotrichum candidum from South Carolina peaches are linked to point mutations in GcCYP51B gene","author":"Gelain","year":"2024","journal-title":"Plant Dis"}],"container-title":["Journal of Infection and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034124003460?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034124003460?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,28]],"date-time":"2024-12-28T08:38:35Z","timestamp":1735375115000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876034124003460"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S1876034124003460"],"URL":"https:\/\/doi.org\/10.1016\/j.jiph.2024.102612","relation":{},"ISSN":["1876-0341"],"issn-type":[{"value":"1876-0341","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epidemiological characteristics of invasive Aspergillus isolates: Morphology, drug susceptibility, and mutations in azole drug targets","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Public Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiph.2024.102612","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences.","name":"copyright","label":"Copyright"}],"article-number":"102612"}}